by

Yomi Robotic Dental Implant System Drives Increased Implant Volume and Practice Profitability According to Growth Study

Dental Economics publishes study by leading Missouri dentist Dr. Jonathan Ehlers on how dental practices are increasing implant volume, efficiency, and profitability by offering robot-guided implant placement.

MIAMI, Sept. 30, 2024 — Neocis®, the global leader in robot-assisted dental implant surgery, and Dr. Jonathan Ehlers, owner of Tiger Family Dental in Sedalia, Missouri, recently authored a paper on the relationship between implant volume and adoption of robot-assisted implant surgery.

 

Published by Dental Economics earlier this month, the in-depth analysis is based on two years of data provided by Tiger Family Dental and ten other general dentistry practices across the country that place implants with Yomi®.

 

In “Adopt the Yomi robotic system to increase implant volume and profitability for your practice”, Ehlers compares each office’s implant volume one year before and one year after robotic implementation. Prior to Yomi adoption, these practices were placing anywhere from 21 to 761 dental implants annually. After a full year with Yomi, every office had grown its total implant volume. The average growth percentage among the group was 137% – with a median increase of 70 implants. One of the practices, which is located in Austin, Texas, placed 529% more implants in its first year with the Yomi platform.

 

“Adopting robotic technology for dental implant placement can have a positive economic effect on the user’s practice,” said Ehlers. “Using robotic technology can increase implant procedural growth and patient throughput by cultivating a modern, digital practice.”

 

Robot-assisted implantation is made possible by Yomi, the only U.S. Food and Drug Administration-cleared robotic system for dental implant surgery. The Yomi platform assists clinicians during all phases of bone preparation and implant placement via streamlined digital planning and haptic guidance of surgical instrumentation. This allows users to place implants more accurately and precisely than any other treatment modality available. To date, more than 60,000 implants have been placed with robotic assistance.

 

“There is tremendous opportunity for providers to increase their share of the rapidly growing dental implant market,” said Alon Mozes, Neocis’ co-founder and CEO. “And our technology can help them accomplish just that. We were thrilled to see Dr. Ehler’s data, which illustrates how Yomi providers are growing their businesses while also providing state-of-the-art clinical care.”

 

About Yomi
The Yomi robotic system is a computerized robotic navigational system intended to provide assistance in both the planning and intraoperative phases of dental implantation surgery. The system can also be used to plan and execute guided alveoloplasty of the mandible and/or maxilla. Yomi is intended for use in partially edentulous and fully edentulous adult patients who qualify for dental implants. Visit neocis.com to learn more about Yomi or schedule a hands-on demo.

 

About Neocis
Neocis is transforming dental surgery with robotics. The company collaborates closely with leading clinicians to develop innovative technologies that help advance patient care and improve quality of life. Based in Miami, Neocis is venture-backed with funding from Mirae Asset Financial Group, NVentures, Intuitive Ventures, DFJ Growth, Mithril Capital Management, Norwest Venture Partners, Vivo Capital, Section 32, and surgical robotics pioneer Fred Moll. For more information, visit neocis.com.

 

About Jonathan Ehlers, DDS
Dr. Jonathan Ehlers is a general dentist in private practice in Sedalia, Missouri. Owner of Tiger Family Dental, a surgery-focused practice, Ehlers has been placing implants for more than a decade and began using the Yomi platform in 2022. He is a graduate of the University of Missouri-Kansas City School of Dentistry and a member of the American Dental Association and Academy of General Dentistry.

 

Contact
For more information, please contact the Neocis media relations team at info@neocis.com.

by

Robot-Assisted Dental Implant Placement Most Accurate and Precise Treatment Modality According to Landmark Study by Leading Oral Surgeon

Dr. Jay Neugarten, an international thought leader in implant dentistry and early adopter of dental robotics, publishes clinical study on the unparalleled accuracy and precision of dental implantation assisted by the Yomi® robotic platform.

MIAMI, March 06, 2024 — New York-based oral and maxillofacial surgeon Dr. Jay Neugarten recently authored a large prospective single-arm clinical study evaluating the accuracy and precision of robot-guided implant surgery.

Published in The International Journal of Oral & Maxillofacial Implants, “Accuracy and Precision of Haptic Robotic-Guided Implant Surgery in a Large Consecutive Series” found that haptic robotic guidance enables higher accuracy and statistically greater precision than any other implant surgery method, including static guides, dynamic computer navigation, and freehand placement.

 

The study was based on 273 robot-guided endosteal implants placed by Neugarten over a two-year period. On average, these implants deviated from their planned angulation and depth by less than 1.5 degrees and less than 0.2 mm, respectively. Published literature and meta-analyses on other guided modalities show angulation errors as high as 3 to 6 degrees. The Yomi system also proved to be significantly more precise than any other treatment method in use today.“

 

I wanted to conduct this research because accuracy is so critical in implant dentistry,” said Neugarten. “In addition to poor aesthetic outcomes, inaccurate implant placement can also lead to intraoperative complications, patient discomfort, and reduced implant longevity. That is why any technology that can deliver this level of exactness should be strongly considered by clinicians.”

 

Robot-assisted implantation is made possible by Yomi, a U.S. Food and Drug Administration-cleared robotic system for dental surgery that is designed and manufactured by Miami-based startup Neocis®. Through a combination of in-depth virtual planning and haptic guidance of surgical instrumentation, the Yomi platform helps dental professionals execute implant placement with a high degree of accuracy and efficiency. To date, more than 47,000 implants have been placed with robotic assistance. Approximately every six minutes a dental implant is placed robotically, according to current data from Neocis.

 

“Thanks to Dr. Neugarten’s rigorous analysis, we can now definitively say robotic implant surgery provides unmatched accuracy and precision,” said Alon Mozes, Neocis’ co-founder and CEO. “This data reinforces what we have been hearing for years from the clinicians we work with. It’s very gratifying, and we believe this cements Yomi as the new standard of care.”

 

About Yomi
The Yomi robotic system is a computerized robotic navigational system intended to provide assistance in both the planning and intraoperative phases of dental implantation surgery. The system can also be used to plan and execute guided alveoloplasty of the mandible and/or maxilla. Yomi is intended for use in partially edentulous and fully edentulous adult patients who qualify for dental implants. Visit neocis.com to learn more about Yomi or schedule a hands-on demo.

 

About Neocis
Neocis is transforming dental surgery with robotics. The company collaborates closely with leading clinicians to develop innovative technologies that help advance patient care and improve quality of life. Based in Miami, Neocis is venture-backed with funding from Mirae Asset Financial Group, NVentures, Intuitive Ventures, DFJ Growth, Mithril Capital Management, Norwest Venture Partners, Vivo Capital, Section 32, and surgical robotics pioneer Fred Moll. For more information, visit neocis.com.

 

About Jay M. Neugarten, DDS, MD, FACS
Dr. Jay Neugarten is an oral and maxillofacial surgeon in private practice in New York City and on Long Island. The team at the New York Center For Orthognathic and Maxillofacial Surgery has been using the Yomi system since 2020. Neugarten is also an educator and active lecturer. He is an associate clinical professor at New York Hospital Cornell-Weill Medical Center and North Shore University-Long Island Jewish Medical Center. Neugarten earned his dental degree from the Columbia University School of Dental and Oral Surgery and medical degree from the Stony Brook School of Medicine.

 

Contact
For more information, please contact the Neocis media relations team at info@neocis.com.

by

Dental robotics leader Neocis secures $20M in funding

Despite challenging macroeconomic conditions, Neocis secured $20M in financing in 2023 to accelerate growth, with funding participation from Mirae Asset Financial Group and NVIDIA.

MIAMI, Jan. 10, 2024 — Neocis®, the global leader in robot-assisted dental implant surgery, announced today that the company has raised $20M in additional funding. This latest round of financing included Mirae Asset Capital/Mirae Asset Venture Investment, venture capital firms affiliated with the Mirae Asset Financial Group that invest in growth-stage healthcare and technology businesses, and NVentures, NVIDIA’s venture capital arm.

 

Headquartered in Miami, Neocis manufactures and markets Yomi®, dentistry’s first and only robotic surgical system cleared by the U.S. Food and Drug Administration (FDA). The Yomi platform, which has received a total of 16 FDA 510(k) clearances, assists clinicians during all phases of implant placement via streamlined digital planning and haptic guidance of surgical instrumentation, so users can deliver precise and efficient treatment. To date, more than 40,000 implants have been placed with robotic assistance. A dental implant is placed with Yomi approximately every six minutes, according to current data from Neocis.

 

“The latest investment is a testament to our growth as a company and how far dental robotics has come since the first Yomi systems were installed,” said Alon Mozes, Neocis’ co-founder and CEO. “We’re tremendously grateful to have the backing of our newest investors, including NVentures and Mirae Asset Financial Group, as well as our existing partners. This funding positions us for continued success in the market and will help us drive meaningful innovation in implant dentistry.”

 

Neocis, which was named one of South Florida’s 50 fastest growing companies last year by the South Florida Business Journal, will use these additional funds to bolster a wide range of business initiatives from product development and sales enablement to clinical education. To keep pace with the company’s steady growth, Neocis moved into a larger space last summer. The new headquarters, which houses a state-of-the-art manufacturing facility, is located in Miami’s bustling Wynwood neighborhood.

 

“Neocis is bringing needed innovation to dentistry, and we couldn’t be more excited to support them in that mission,” said Mirae Asset Capital’s Investment Manager, Soojung Kim. “We look forward to working alongside the Neocis team to help them excel in a rapidly growing market and get Yomi in the hands of more providers.”

 

“Robotics and AI are changing the face of dentistry, enabling innovations that increase doctor efficiency and help them improve the quality of life for their patients,” said Mohamed “Sid” Siddeek, corporate vice president and head of NVentures. “Neocis is transforming dental implant procedures, demonstrating the benefits of robotics and AI in healthcare.”

 

To learn more about Neocis and the Yomi platform, visit neocis.com.

 

About Yomi
Yomi is a computerized robotic navigational system intended to provide assistance in both the planning and intraoperative phases of dental implant surgery. The platform can also be used to plan and execute robot-guided alveoloplasty. Yomi is intended for use in partially edentulous and fully edentulous adult patients who qualify for dental implants. Visit neocis.com to learn more about Yomi or schedule a hands-on demo.

 

About Neocis
Neocis is transforming dental surgery with robotics. The company collaborates closely with leading clinicians across all dental specialties to develop innovative technologies that help advance patient care and improve quality of life. Based in Miami, Neocis is venture-backed with funding from NVentures, Mirae Asset Financial Group, Intuitive Ventures, DFJ Growth, Mithril Capital Management, Norwest Venture Partners, Vivo Capital, Section 32, and surgical robotics pioneer Fred Moll. For more information, visit neocis.com.

 

Contact
For more information, please contact the Neocis media relations team at info@neocis.com.

by

Yomi Robotic Platform’s New Bone Reduction Feature Launches Commercially

Latest indication allows clinicians to leverage the accuracy, precision, and intraoperative flexibility of robotic assistance when performing alveoloplasty – a key phase of many full-arch cases

MIAMI, April 12, 2023 — Neocis®, manufacturer of Yomi® and the global leader in robot-assisted dental surgery, announced today the official market launch of the platform’s bone reduction module. Cleared by the U.S. Food and Drug Administration (FDA) in November of 2022, this latest offering from Neocis enables dental professionals to use Yomi to precisely plan bone reduction (using a patient’s CT scan) and then execute the treatment plan with the help of robotic guidance.

 

Yomi, the first and only FDA-cleared robotic system for dental surgery, assists clinicians in planning and operative phases of dental implant placement via interactive digital planning (using YomiPlan™ software) and haptic guidance of surgical instrumentation. The Yomi platform, which received a prized Cellerant Best of Class Technology Award last summer, has helped general dentists and specialists place more than 28,000 implants and perform upwards of 16,000 robot-guided cases. Every ten minutes a dental implant is placed robotically, according to current data from Neocis.

 

Alveoloplasty is a common dental procedure during which the surface of a patient’s alveolar bone is reshaped and reduced to prepare a foundation for a full-arch restoration. Achieving a smooth, level ridge with enough room for a prosthesis contributes to predictable, long-lasting outcomes. Yomi’s bone reduction module, Neocis’ 14th FDA clearance, is designed to help clinical teams throughout the planning and intraoperative phases of this procedure, so they can perform complex full-arch cases with confidence and efficiency.

 

“I’ve been doing full-mouth reconstruction for a long time, and I can say that Yomi takes bone reduction to the next level,” said Dr. Sanju Jose, a periodontist in the Baltimore-Washington metropolitan area and one of the first clinicians in the country to use this new feature in a live surgical setting. “After just a few cases, I knew this functionality would be a game-changer for us. Every time my team uses Yomi for ridge reduction, we look at each other and say, ‘this is amazing.’”

 

Robot-guided alveoloplasty is a novel approach that avoids some of the drawbacks associated with traditional surgical methods. Yomi physically prevents the user from moving the cutting bur beyond the precise reduction boundaries defined in the treatment plan and provides a clear virtual reference of how much bone has been removed. Unlike physical guides, robotic assistance enables intraoperative treatment modifications, allows for unobstructed visualization, irrigation, and palpation of the surgical site, and doesn’t require the clinician to reflect large flaps, which helps maintain blood supply to the bone.

 

“Yomi saves me a bunch of time by allowing me to precisely plan every dimension of the reduction volume for each patient,” said Dr. Scott Clayhold, an oral and maxillofacial surgeon in the Seattle area. “Then, I have the clinical flexibility to take the bur where I want, knowing that Yomi will prevent me from going beyond the boundaries I’ve set in my plan. That’s the beauty of robot-guided surgery.”

 

To learn more about the Yomi system and this new clinical offering, visit neocis.com/bone-reduction.

 

About Yomi
The Yomi robotic system is a computerized robotic navigational system intended to provide assistance in both the planning (preoperative) and the surgical (intraoperative) phases of dental implantation surgery. The system provides software to preoperatively plan dental implantation procedures and provides robotic navigational guidance of the surgical instruments. The system can also be used for planning and performing guided bone reduction (also known as alveoloplasty) of the mandible and/or maxilla. Yomi is intended for use in partially edentulous and fully edentulous adult patients who qualify for dental implants.

 

Since 2016, Yomi has been helping clinicians around the country plan and place dental implants with a high level of precision and efficiency, so they can operate with confidence, expand their practices, and deliver an excellent patient experience. The platform has assisted in the placement of more than 28,000 implants. Visit neocis.com to learn more about Yomi or schedule a hands-on demo.

 

About Neocis
Neocis is transforming dental surgery with robotics. The company collaborates closely with leading clinicians to develop innovative technologies that help advance patient care and improve quality of life. Based in Miami, Neocis is venture-backed with funding from Intuitive Ventures, DFJ Growth, Mithril Capital Management, Norwest Venture Partners, Vivo Capital, Section 32, and surgical robotics pioneer Fred Moll. For more information, visit neocis.com.

 

Contact
For more information, please contact the Neocis media relations team at info@neocis.com.

by

Neocis’ Yomi Robotic System Receives FDA 510(k) Clearance for Bone Reduction

New bone reduction feature expands the scope of robot-assisted dental surgery by enabling clinicians to use the Yomi platform for more phases of full-arch rehabilitation

MIAMI, Nov. 15, 2022 — Neocis®, manufacturer of Yomi® and the global leader in robot-assisted dental implant surgery, announced today that the Yomi system has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for guided bone reduction – Neocis’ second FDA clearance this year and 14th to date.

 

Yomi, the first and only FDA-cleared robotic system for dental surgery, assists clinicians in planning and operative phases of dental implant placement via interactive digital planning (using YomiPlan™ software) and physical guidance of surgical instrumentation, respectively. The Yomi robot, which received a Cellerant Best of Class Technology Award this summer, has been used in the placement of more than 21,000 implants and 850+ full-arch cases since its commercial launch.

 

This new indication allows dental professionals to perform robot-guided alveoloplasty of the mandible and/or maxilla (commonly referred to as bone reduction), helping them take on complicated full-arch cases with confidence and efficiency. First, a patient’s CT scan is used to digitally plan the bone reduction and placement of implants. During a procedure, Yomi’s guide arm provides haptic feedback to keep the burr from deviating beyond pre-planned resection boundaries. Unlike static guides, robot-assisted bone reduction allows clinicians to freely visualize, irrigate, and palpate the surgical site as well as modify their treatment plan intraoperatively without sacrificing accuracy.

 

This combination of in-depth virtual planning and robotic guidance helps the user achieve a smooth, level ridge, which is critical to predictable and lasting restorative outcomes. Currently in the midst of a multi-site limited market release, Yomi’s bone reduction functionality is expected to be commercially available early next year.

 

“Not only does this allow implant clinicians to tackle full-arch restoration with a whole new level of accuracy and confidence, it pushes robot-assisted dental surgery into exciting new territory,” said Alon Mozes, Neocis Co-founder and CEO. “This clearance is one of our most significant yet, as dental professionals can now use Yomi to perform truly volumetric 3D surgery.”

 

Ridge reduction, an important preliminary step in many full-arch cases, involves flattening the surface of a patient’s alveolar bone to create a stable foundation for multiple implants, which are used to anchor a full-arch prosthesis.

 

“Neocis continues to push the limits of implant dentistry, and Yomi’s new bone reduction functionality is a clear testament to that,” said Dr. Donald Nikchevich, an oral and maxillofacial surgeon based in Southern California and Yomi Diamond Doctor of Excellence. “As someone who performs full-arch rehabilitation regularly, I’m excited to be able to execute ridge reduction with the accuracy, efficiency, and confidence that surgical robotics affords.”

 

This new indication was cleared by the FDA just a few weeks after Neocis announced the close of an oversubscribed $40 million funding round, led by one of the dental industry’s largest specialist investors. They were joined by Intuitive Ventures, the independent VC arm of Intuitive Surgical, and several of Neocis’ existing partners.

 

About Yomi
The Yomi robotic system is a computerized robotic navigational system intended to provide assistance in both the planning (preoperative) and the surgical (intraoperative) phases of dental implantation surgery. The system provides software to preoperatively plan dental implantation procedures and provides robotic navigational guidance of the surgical instruments. The system can also be used for planning and performing guided bone reduction (also known as alveoplasty) of the mandible and/or maxilla. Yomi is intended for use in partially edentulous and fully edentulous adult patients who qualify for dental implants.

 

Since 2016, Yomi has been helping clinicians around the country plan and place dental implants with a high level of precision and efficiency, so they can operate with confidence, expand their practices, and deliver an excellent patient experience. The platform has assisted in the placement of more than 21,000 implants. Visit neocis.com to learn more about Yomi or schedule a hands-on demo.

 

About Neocis
Neocis is transforming dental surgery with robotics. The company collaborates closely with leading clinicians to develop innovative technologies that help advance patient care and improve quality of life. Based in Miami, Neocis is venture-backed with funding from Intuitive Ventures, DFJ Growth, Mithril Capital Management, Norwest Venture Partners, Vivo Capital, Section 32, and surgical robotics pioneer Fred Moll. For more information, visit neocis.com.

 

Contact
For more information, please contact the Neocis media relations team at info@neocis.com.

by

Neocis Secures $40M in Additional Funding to Continue Transforming Dental Surgery With Robotics

Neocis closed its latest round of funding, led by a prominent dental investor, with participation from Intuitive Ventures and existing partners DFJ Growth, Vivo Capital, Mithril Capital Management, Norwest Venture Partners, and Fred Moll. This additional funding comes as robotic adoption within implant dentistry continues to increase dramatically; to date, the Yomi system has been used to place more than 20,000 implants. 

MIAMI, Oct. 27, 2022  — Neocis®, manufacturer of Yomi® and the global leader in robot-assisted dental implant surgery, announced today that the company has completed its latest round of financing. 


The oversubscribed $40M round was led by one of the dental industry’s largest specialist investors. They were joined by Intuitive Ventures, the independent VC arm of Intuitive Surgical that is accelerating the future of minimally invasive care. These new investors were joined by Neocis’ existing partners, bringing total investment in the Miami-based business to more than $160 million since its founding in 2009. 


Started by Alon Mozes and Juan Salcedo, Neocis manufactures and markets Yomi, dentistry’s first and only FDA-cleared robotic surgical system. The innovative platform assists clinicians during all phases of implant placement via streamlined digital planning and haptic guidance of surgical instrumentation–so they can place implants with accuracy, efficiency, and confidence. The Yomi system is often used to perform flapless procedures, a less invasive surgical approach with proven patient benefits.


“Neocis shares Intuitive Ventures’ commitment to advancing positive patient outcomes in minimally invasive care through innovative technology and solutions,” said Oliver Keown, MD, Managing Director at Intuitive Ventures. “We believe Neocis’ deep commitment to addressing customer and patient need through a broadening robotic ecosystem and their impressive technology platform that expands access to high-quality dental care, makes them a transformative force in this rapidly evolving market.”


This latest infusion of capital will allow Neocis, which the South Florida Business Journal recently named one of the fastest growing companies in South Florida, to advance its mission of transforming dental surgery through advanced robotics. The company will use these funds to continue accelerating research and development efforts, bolstering marketing and educational initiatives, and expanding the footprint of its sales, clinical support, and business optimization teams.


“We are thrilled to be joined by discerning investors aligned with Neocis’ mission to advance precision dentistry,” said Ajay Royan, Managing General Partner and Founder of Mithril Capital Management, an early investor in Neocis. “The future of dental robotics is limitless, and this latest round of capital will help the Neocis team continue innovating at the highest level.”


“For a company in the dental robotics space, I couldn’t dream up a better syndicate of investors than this,” said Alon Mozes, Neocis Co-Founder and CEO. “This new backing underscores Neocis’ strong position in a growing market and will help us further our product development and commercial efforts.”


The finalization of this new round of funding comes just a few months after Yomi was named one of the best dental technologies of the year by Dental Products Report and Cellerant Consulting Group–the first time a Neocis product has received a Cellerant Best of Class Technology Award. 


To learn more about Neocis and the Yomi system, visit neocis.com. 


About Intuitive Ventures
Intuitive Ventures is accelerating the future of minimally invasive care. Leveraging Intuitive’s entrepreneurial spirit, industry-leading knowledge, innovative technologies, and commercial reach, Intuitive Ventures invests in transformative opportunities advancing positive outcomes in healthcare. The team develops meaningful, long-term relationships with groundbreaking early-stage start-ups with tremendous financial opportunity that are leading the way in advancing minimally invasive care. Through its inaugural $100 million fund and with leadership combining decades of investing and operational experience, the Intuitive Ventures team is transforming minimally invasive care. Learn more at ventures.intuitive.com


About Yomi
Yomi is a computerized robotic navigational system intended to provide assistance in both the planning (preoperative) and the surgical (intraoperative) phases of dental implantation surgery. The system provides software to preoperatively plan dental implantation procedures and provides robotic navigational guidance of the surgical instruments. Yomi is intended for use in partially edentulous and fully edentulous adult patients who qualify for dental implants.
Since 2016, Yomi has been helping clinicians around the country plan and place dental implants with a high level of precision and efficiency, so they can operate with confidence, expand their practices, and deliver an excellent patient experience. The platform has assisted in the placement of more than 20,000 implants. Visit neocis.com to learn more about Yomi or schedule a hands-on demo.


About Neocis
Neocis is transforming dental surgery with robotics. The company collaborates closely with leading clinicians to develop innovative technologies that help advance patient care and improve quality of life. Based in Miami, Neocis is venture-backed with funding from Intuitive Ventures, DFJ Growth, Mithril Capital Management, Norwest Venture Partners, Vivo Capital, Section 32, and surgical robotics pioneer Fred Moll. For more information, visit neocis.com.


Contact
For more information, please contact the Neocis media relations team at info@neocis.com.